Fojo T et al. “Unintended consequences of expensive cancer therapeutics – the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity” JAMA Otolaryngology Head and Neck Surgery (2014).

Prescrire (2014); 34 (364):132-136 ‘New drugs and indications in 2013: little real progress but regulatory authorities take some positive steps’ available at http://www.ncbi.nlm.nih.gov/pubmed/24860905